Adicet Bio
ACET
ACET
55 hedge funds and large institutions have $36.2M invested in Adicet Bio in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.42% more ownership
Funds ownership: 5.18% → 6.6% (+1.4%)
58% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 19
Holders
55
Holding in Top 10
–
Calls
$12K
Puts
$3K
Top Buyers
| 1 | +$6.25M | |
| 2 | +$3.12M | |
| 3 | +$2.05M | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$834K |
| 5 |
D.E. Shaw & Co
New York
|
+$387K |
Top Sellers
| 1 | -$1.77M | |
| 2 | -$1.23M | |
| 3 | -$447K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$334K |
| 5 |
RL
Ruffer LLP
London,
United Kingdom
|
-$313K |